Authors:
MILPIED N
GAILLARD F
MOREAU P
MAHE B
SOUCHET J
RAPP MJ
BULABOIS CE
MORINEAU N
HAROUSSEAU JL
Citation: N. Milpied et al., HIGH-DOSE THERAPY WITH STEM-CELL TRANSPLANTATION FOR MANTLE CELL LYMPHOMA - RESULTS AND PROGNOSTIC FACTORS, A SINGLE-CENTER EXPERIENCE, Bone marrow transplantation, 22(7), 1998, pp. 645-650
Authors:
MILPIED N
GAILLARD F
MOREAU P
MAHE B
SOUCHET J
RAPP MJ
BULABOIS CE
MORINEAU N
HAROUSSEAU JL
Citation: N. Milpied et al., HIGH-DOSE THERAPY (HDT) WITH STEM-CELL TRANSPLANTATION (BMT) FOR MANTLE CELL LYMPHOMA (MCL) - RESULTS AND PROGNOSTIC FACTORS - A SINGLE-CENTER EXPERIENCE, Bone marrow transplantation, 21, 1998, pp. 596-596
Authors:
MILPIED N
GAILLARD F
MOREAU P
SOUCHET J
MAHE B
RAPP MJ
BULABOIS CE
MORINEAU N
HAROUSSEAU JL
Citation: N. Milpied et al., MYELOABLATIVE THERAPY WITH STEM-CELL SUPPORT (BMT) IS FEASIBLE AND EFFECTIVE IN MANTLE CELL LYMPHOMA (MCL) - A SINGLE-CENTER EXPERIENCE OVER 5 YEARS, Experimental hematology, 25(8), 1997, pp. 18-18
Authors:
MILPIED N
GAILLARD F
MOREAU P
MAHE B
SOUCHET J
RAPP MJ
BULABOIS CE
MORINEAU N
HAROUSSEAU JL
Citation: N. Milpied et al., HIGH-DOSE THERAPY (HDT) WITH STEM-CELL TRANSPLANTATION (BMT) FOR MANTLE CELL LYMPHOMA (MCL) - RESULTS AND PROGNOSTIC FACTORS - A SINGLE-CENTER EXPERIENCE, Blood, 90(10), 1997, pp. 1693-1693